Joints, heart tissues, and bones are some of the main targets of inflammation-driven damage possible if you have rheumatoid arthritis While medications can help manage RA, they may also lead to ...

Rheumatoid arthritis (RA) can be mild, moderate, or severe, and symptoms vary from person to person. Learn more about the stages of RA, along with treatment options.

Rheumatoid arthritis is a painful and disabling autoimmune disease that affects more than 1% of people worldwide. In the United States alone, it disrupts the lives of about 1.3 million people.

A woman in her late 20s, who was diagnosed with rheumatoid arthritis, has taken to social media to outline the early warning signs of the condition, after initially dismissing her symptoms as ...

Summer is the time for fresh fruits. If you’ve got rheumatoid arthritis (RA), take advantage of the seasonal abundance and increase your consumption as part of an RA-friendly diet. Fruits are ...

According to the American Academy of Orthopedics, over 85% of people aged 60 and above were found to have cervical arthritis as of April 2021. What is the disease and what are its causes, symptoms ...

Meditation Therapy for Rheumatoid Arthritis Patients Arthritis Care Research News Alerts. 2007;57 (7):1134-1142. 0 ...

Thumb arthritis tends to worsen with age as it wears down your joints. If caught early, you can start treatment quickly, which may help reduce pain and limit the thumb stiffness you experience later.

1. It’s Crucial That People With Rheumatoid Arthritis Stay Up to Date With the COVID-19 Vaccine COVID-19 is a serious disease. It has killed more than a million Americans, per the CDC, and has ...

GLP-1 receptor agonists may significantly reduce the risk for cardiovascular events in patients with rheumatoid arthritis treated with Janus kinase inhibitors, according to data presented at the ...

Experts explain how to manage arthritis flare-ups this summer Camilla Foster Fri, June 13, 2025, 3:24 AM PDT Arthritis flares in warmer summer months are common ...

Alan Reynolds; Andrew S Koenig; Eustratios Bananis; Amitabh Singh Disclosures Expert Rev Pharmacoeconomics Outcomes Res. 2012;12 (3):319-333.